Safety and Efficacy of Intravenous Cladribine in Multiple Sclerosis Patients

被引：0
|
作者：
Alchaki, Abdul Rahman [1 ]
Anadani, Nidhiben [2 ]
Cook, Stuart [3 ]
机构：
[1] Rutgers State Univ, Clifton, NJ USA
[2] Rutgers State Univ, Newark, NJ USA
[3] Rutgers State Univ, Newark, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P039
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [31] Mitoxantrone in multiple sclerosis: efficacy and safety in 123 patients
    Renoux, C
    Vukusic, S
    Durand-Dubief, E
    Gignoux, L
    Achiti, I
    Blanc, S
    Confavreux, C
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S267 - S267
  • [32] Mitoxantrone in multiple sclerosis: Efficacy and safety in 123 patients
    Vukusic, S.
    Renoux, C.
    Durand-Dubief, F.
    Gignoux, L.
    Achiti, I.
    Blanc, S.
    Confavreux, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 122 - 122
  • [33] Analysis of Evusheld Safety and Efficacy in Multiple Sclerosis Patients
    Liu, E. N.
    Whitmire, N.
    Perez, A.
    Wilder, C.
    Rosengren, S.
    Yang, J. H.
    Kinkel, R. P.
    Graves, J.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 66 - 66
  • [34] Efficacy and safety of alemtuzumab in Korean multiple sclerosis patients
    Kim, Hyunjin
    Lee, Eun-Jae
    Kim, Sung Keun
    Kim, Kwang-Kuk
    Lim, Young-Min
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 30 : 247 - 251
  • [35] Intravenous cyclophosphamide and mitoxantrone therapy in multiple sclerosis: a comparative study of efficacy and safety
    Zipoli, V.
    Portaccio, E.
    Hakiki, B.
    Siracusa, G.
    Sorbi, S.
    Amato, M. P.
    MULTIPLE SCLEROSIS, 2006, 12 : S214 - S215
  • [36] Efficacy and safety profiles of cladribine in highly active multiple sclerosis: a tertiary MS center experience in Turkey
    Sokmen, O.
    Ozen, P. Acar
    Tuncer, A.
    Karabudak, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 864 - 864
  • [37] CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE
    Pakpoor, Julia
    Disanto, Giulio
    Altmann, Daniel R.
    Pavitt, Sue
    Turner, Benjamin
    Calado-Marta, Monica
    Juliusson, Gunnar
    Baker, David
    Chataway, Jeremy
    Schmierer, Klaus
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [38] Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
    Giovannoni, Gavin
    Sorensen, Per Soelberg
    Cook, Stuart
    Rammohan, Kottil
    Rieckmann, Peter
    Comi, Giancarlo
    Dangond, Fernando
    Adeniji, Abidemi K.
    Vermersch, Patrick
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (12) : 1594 - 1604
  • [39] Safety and efficacy of cladribine therapy following a treatment with anti-CD20 compounds in relapsing multiple sclerosis patients: a pilot study
    Sacco, R.
    Disanto, G.
    Pravata, E.
    Gobbi, C.
    Zecca, C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 852 - 852
  • [40] Safety and tolerability of subcutaneous cladribine therapy in chronic progressive multiple sclerosis
    OConnor, PW
    Selby, R
    Brandwein, J
    Gray, TA
    NEUROLOGY, 1997, 48 (03) : 3071 - 3071
12345